
Opinion|Videos|May 7, 2024
Clinical Efficacy of Non-Statin Treatment Options in ASCVD
Focusing on PCSK9 inhibitors, inclisiran, and bempedoic acid, the panel compares treatment efficacy and outlines patient factors that influence treatment decisions.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Tradipitant Becomes First Treatment Approved for Vomiting Due to Motion Sickness in 4 Decades
2
Expanding Access to MOUD: The Psychiatric Pharmacist’s Role in Optimization
3
Aspirin Dosage and Decision-Making: What Pharmacists Should Know
4
Psychiatric Pharmacists Take a Larger Role in Substance Use Disorder Care
5













































































































































































































